Free Articles at Neutron Marketing Logo Your Ad Here







  • Make cash!

  • Search:


    Add By AdBrite
    Your Ad Here

    Author Spotlight
    No Image ChristopherSt..
    Articles: 6

    No Image ToddMartin
    Articles: 19

    No Image sharewaremsin
    Articles: 6

    No Image PeterWilson
    Articles: 17

    No Image AmyNutt
    Articles: 61


    More Sponsors

    Creative
Commons License

    This article is licensed under a Creative Commons Attribution-No Derivative Works 3.0 Unported License, which means you may freely reprint it, in its entiretly, provided you include the author's resource box along with LIVE links (without "nofollow" tags).

    Free Articles at Neutron Marketing Article Publishing and Distribution » Cancer » Faces of DARPP-32: Master Signaling Mediator in the Brain?
    Faces of DARPP-32: Master Signaling Mediator in the Brain?

    Previous Article - Data Validation through Tissue Analysis
    Next Article - Alternative Prostate Cancer Treatment

    View PDF | Print View | Html Version
    by: Stephen Jones
    Total views: 27
    Word Count: 244

    As a major target for dopamine-activated adenylyl cyclase and protein kinase A in the striatum, DARPP-32 plays a central role in regulating the efficacy of dopaminergic neurotransmission and can act either as a phosphatase or kinase inhibitor in a contextually dependent manner. Growing evidence points to DARPP-32 as a key mediator/modulator in numerous signal transduction cascades implicated in a growing number of neurological disorders such as schizophrenia and depression, as well as in drug abuse and addiction.  For example, it has been shown that acute exposure of mice to cocaine increases phosphorylation of DARPP-32 at Thr34 with a concommitment decrease in phosphorylation at Thr75, whereas chronic exposure leads to a reversal of this phospho profile.  It has also been observed that many schizophrenic patients show decreased levels of DARPP-32 in the prefrontal cortex.

     

    For More Information About “ DARPP-32”

    Visit http://www.imgenex.com/emarketing/112707_DARP32/DARP-32_112707_web.htm

    While the precise role that DARPP-32 plays in these psychiatric disorders is still being elucidated, the existing body of literature clearly portrays DARPP-32 as playing a central role in multiple signaling pathways.  Further research will determine neuronal subpopulations where phosphorylation of DARPP-32 occurs as well as the functional importance of previously identified phospho sites of DARPP-32.

     

    IMGENEX offers over one-thousand Neuroscience-related antibodies such as recently cited anti-DARPP-32 (pan and phosphospecific), Dopamine D1 and D2 Receptors (IHC validated), 5-HT Receptors (such as 5-HT1B), Adenosine Receptor, NMDA and more!

    About the Author

    For More Information About “ DARPP-32

    Visit http://www.imgenex.com/emarketing/112707_DARP32/DARP-32_112707_web.htm

    Sponsor
    Your Ad Here

    Rating
    Rating: Not yet rated

    Comments
    No comments posted.

    Add Comment


    Enter the code shown

    Visual CAPTCHA


    Previous Article - Data Validation through Tissue Analysis
    Next Article - Alternative Prostate Cancer Treatment